stockrowCibus, Inc. (CBUS) vs Rallybio Corporation (RLYB)
- Cibus, Inc. CBUS 1.17 +2.63%
- Rallybio Corporation RLYB 15.75 +0.38%
Cibus, Inc. and Rallybio Corporation are both Biotechnology companies. Cibus, Inc. and Rallybio Corporation are of similar size ($87.1M and $84.5M). Cibus, Inc. has negative trailing earnings, so its P/E is not meaningful; Rallybio Corporation trades at 3.3×. Rallybio Corporation grew revenue faster over the last twelve months: 1.18% against −10.3%. Rallybio Corporation has the higher net margin (0.00% vs −2,258.9%) and the lower return on invested capital (−944.4% vs 0.00%). Across the 16 metrics below, Rallybio Corporation leads on 13 and Cibus, Inc. on 3.
Valuation
Profitability
| Metric | CBUS | RLYB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (1,450.59%) | 0.00% | 0.00% |
| Net margin | (2,258.89%) | 0.00% | 0.00% |
| Free cash flow margin | (1,064.60%) | 0.00% | 0.00% |
| Return on equity | (219.97%) | 34.52% | (51.96%) |
| Return on assets | (29.77%) | 32.85% | (46.06%) |
| Return on invested capital | 0.00% | (944.36%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack